Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom
Osteoporos Int. 2019 Jul 3. doi: 10.1007/s00198-019-05064-w Svedbom A, Hadji P, Hernlund E, Thoren R, McCloskey E, Stad R, Stollenwerk B. https://www.ncbi.nlm.nih.gov/pubmed/31270592